Integumen's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott after announcing they've secured a new £3mln three-year loan facility that requires no loan repayments until next year. He says the initial drawdown of £1.5mln provides them with sufficient working capital for its COVID-19 AI product development as well as for the expansion of Labskin support services into the US and Asia.
Integumen's Gerry Brandon details new £3mln facility for Labskin and Covid-19 expansion
